Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population

Abstract

Owing to their agonist action on dopaminergic systems, cannabinoids may play a major role in substance dependency and schizophrenia. We examined the (AAT)n triplet repeat polymorphism nearby the CNR1 gene, which encodes human cannabinoid (CB1) receptor, in a male Afro-Caribbean population. The allelic and genotypic distributions were significantly different in non-schizophrenic cocaine dependents (n=97), schizophrenic cocaine dependents (n=45) and matched controls (n=88) (P<10−4). The frequency of the (AAT)12 repeat allele was increased in non-schizophrenic cocaine dependents and schizophrenic cocaine dependents vs controls (25.3 and 26.7 vs 5.7%) (P<10−4). Our results support that the (AAT)n polymorphism nearby the CNR1 gene could be associated with predisposition to cocaine dependency.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Andreasson S, Allebeck P, Engsrom A . Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987; 2: 1483–1485.

    Article  CAS  Google Scholar 

  2. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G . Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002; 325: 1195–1212.

    Article  Google Scholar 

  3. Linszen DH, Dingemans PM, Lenior ME . Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994; 51: 273–279.

    Article  CAS  Google Scholar 

  4. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE . Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325: 1212–1213.

    Article  Google Scholar 

  5. Arseneault L, Cannon M, Witton J, Murray RM . Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004; 184: 110–117.

    Article  Google Scholar 

  6. Krebs MO, Leroy S, Duaux E, Bourdel MC, Griffon N, Laqueille X et al. Vulnerability to cannabis, schizophrenia, the (ATT)n polymorphism of the cannabinoid receptor type 1 (CNR1) gene. Schizophr Res 2003; 53: 72-(A).

    Google Scholar 

  7. Devane WA, Dysarz III FA, Johnson MR, Melvin LS, Howlett AC . Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988; 34: 605–613.

    CAS  Google Scholar 

  8. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI . Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561–564.

    Article  CAS  Google Scholar 

  9. Onaivi ES, Leonard CM, Ishiguro H, Zhang PW, Lin Z, Akinshola BE et al. Endocannabinoids and cannabinoid receptor genetics. Prog Neurobiol 2002; 66: 307–344.

    Article  CAS  Google Scholar 

  10. Romero J, Garcia L, Cebeira M, Zadrozny D, Fernandez-Ruiz JJ, Ramos JA . The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. Life Sci 1995; 56: 2033–2040.

    Article  CAS  Google Scholar 

  11. Mailleux P, Vanderhaeghen JJ . Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate–putamen: an in situ hybridization study. J Neurochem 1993; 61: 1705–1712.

    Article  CAS  Google Scholar 

  12. De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J et al. A cannabinoid mechanism in relapse to cocaine seeking. Nat Med 2001; 7: 1151–1154.

    Article  CAS  Google Scholar 

  13. Hoehe MR, Caenazzo L, Martinez MM, Hsieh WT, Modi WS, Gershon ES et al. Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14–q15. New Biol 1991; 3: 880–885.

    CAS  PubMed  Google Scholar 

  14. Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchik A et al. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics 1997; 43: 1–8.

    Article  CAS  Google Scholar 

  15. Comings DE, Muhleman D, Gade R, Johnson P, Verde R, Saucier G et al. Cannabinoid receptor gene (CNR1): association with i.v. drug use. Mol Psychiatry 1997; 2: 161–168.

    Article  CAS  Google Scholar 

  16. Zhang PW, Ishiguro H, Ohtsuki T, Hess J, Carillo F, Walther D et al. Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol Psychiatry 2004; 9: 916–931.

    Article  CAS  Google Scholar 

  17. Li T, Liu X, Zhu ZH, Zhao J, Hu X, Ball DM et al. No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population. Mol Psychiatry 2000; 5: 128–130.

    Article  Google Scholar 

  18. Covault J, Gelernter J, Kranzler H . Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence. Mol Psychiatry 2001; 6: 501–502.

    Article  CAS  Google Scholar 

  19. Ujike H, Takaki M, Nakata K, Tanaka Y, Takeda T, Kodama M et al. CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Mol Psychiatry 2002; 7: 515–518.

    Article  CAS  Google Scholar 

  20. Bera O, Cesaire R, Quelvennec E, Quillivic F, de Chavigny V, Ribal C et al. HLA class I and class II allele and haplotype diversity in Martinicans. Tissue Antigens 2001; 57: 200–207.

    Article  CAS  Google Scholar 

  21. Nurnberger Jr JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994; 51: 849–859.

    Article  Google Scholar 

  22. Raymond M, Rousset F . GENEPOP: population genetics software for exact tests and ecumenicism. J Heredity 1995; 86: 248–249.

    Article  Google Scholar 

  23. Sham PC, Curtis D . Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995; 59 (Part 1): 97–105.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The study was supported by government contract – MILDT and INSERM – and Cabanis-Pfizer project's grants; we are grateful to the staff of the addiction treatment unit of the Clarac Hospital, Dr Albout, Dr Meyer and all the staff from the blood transfusion center of Martinique.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N Ballon.

Additional information

Duality of interest

None declared.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ballon, N., Leroy, S., Roy, C. et al. (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population. Pharmacogenomics J 6, 126–130 (2006). https://doi.org/10.1038/sj.tpj.6500352

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500352

Keywords

This article is cited by

Search

Quick links